Aramark ARMK Redeemable NCI
Redeemable NCI at other companies
Other financials
Where this comes from
Reported directly by Aramark in its filing.
Tagged under the XBRL concept us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount.
The official record: Aramark’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Aramark's redeemable nci.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Aramark's redeemable NCI?
- Aramark (ARMK) reported redeemable NCI of $61.87M in Q1 2026.
- How has Aramark's redeemable NCI changed year-over-year?
- Aramark's redeemable NCI increased by 351.7% year-over-year, from $13.7M to $61.87M.
- What is the long-term trend for Aramark's redeemable NCI?
- Over 5 years (2020 to 2025), Aramark's redeemable NCI has grown at a 7.2% compound annual growth rate (CAGR), from $9.99M to $14.13M.
- What does redeemable NCI mean?
- Equity held by others that the company may be forced to buy back in the future.
- How do you interpret redeemable NCI?
- An increase indicates higher potential future cash outflows to minority partners, impacting liquidity.
- How does redeemable NCI compare across companies?
- Common in companies with joint ventures or partially owned subsidiaries; peers with wholly-owned structures will have zero.